GSK3B and type 2 diabetes mellitus: However, in patients with type 2 diabetes, the activity of GSK3β is abnormally elevated, leading to excessive inhibition of GS activity, reduced glycogen synthesis, and consequently, elevated blood glucose levels, a phenomenon known as insulin resistance (Xi et al., 2016; Zhang et al., 2014).